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A B S T R A C T
High-throughput functional assays of enhancer activity have recently enabled the genome-scale definition of molecular, structural, and biochemical features of these
genomic regulatory regions. To infer the evolutionary origin of DNA sequences operating as functional enhancers in human embryonic stem cells (hESC), we
examined the patterns of evolutionary conservation and divergence in the genome-wide functional enhancers' landscape of hESC. We show that a prominent majority
(up to 94%) of DNA sequences identified in hESC as functional enhancers are conserved in humans and our closest evolutionary relatives, Chimpanzee and Bonobo.
More than 91% of functional enhancers that are highly conserved in both Chimpanzee and Bonobo, are conserved among other Great Apes and>75% are conserved
in the Rhesus genome. In striking contrast,< 5% of DNA sequences operating in hESC as functional enhancers are conserved in rodents. Conserved in primates
enhancers' sequences are complemented by 1619 sequences of enhancers that are specific to humans. Enhancers that harbor human-specific sequences appear
enriched among the invariant enhancer module maintaining activity in different pluripotent states and these regions are associated with pluripotency- and em-
bryonic-lineage-related genes. However, functional enhancers make up only a minority of all conserved in primates or human-specific transcription factor binding
sites. Our analyses revealed that sequences that are conserved during ~8 million years of primate evolution dominate the genomic landscape of functional enhancers
in both primed and naïve hESC. Collectively, these observations revealed thousands of evolutionarily conserved sequences that function as a core regulatory network
in human embryonic stem cells which has recently undergone further extension after divergence of modern humans from our closest relatives, Chimpanzee and
Bonobo.
1. Introduction
Studies into changes in the DNA during evolution have helped to
shape our understanding of mechanisms of phenotypic changes.
However, despite recent progress and a comprehensive catalogue of
changes within protein-coding genes, the genetic basis of many di-
vergent features remains elusive (Chimpanzee Sequencing and Analysis
Consortium, 2005; Fu et al., 2014; Green et al., 2010; Meyer et al.,
2012; Prufer et al., 2012; Prufer et al., 2014), thus supporting the hy-
pothesis that the evolution of regulatory loci in the genome have con-
tributed to the emergence of unique human phenotypes (King and
Wilson, 1975).
An extensive search for human-specific genomic regulatory loci has
resulted in identification of ~20,000 candidates, the vast majority of
which is located within non-coding regions of the human genome
(Capra et al., 2013; Glinsky, 2015a, 2016a,b,c, 2017, 2018a,b; Konopka
et al., 2012; Marnetto et al., 2014; McLean et al., 2011; Shulha et al.,
2012). Most recently, the analyses of individual genomes of Great Apes
using high-resolution sequencing technologies (Kronenberg et al.,
2018) and applications of novel bioinformatics approaches to genome-
wide expression profiling of human prefrontal cortex (Guffanti et al.,
2018) markedly expanded the compendium of candidate human-spe-
cific regulatory sequences, which currently comprises nearly sixty
thousand genomic loci aligned to the most recent release of the human
reference genome (Glinsky, 2018b).
Transposable elements (TEs) represent a major evolutionary force
contributing to the creation of species-specific regulatory networks in
primate genomes by providing highly efficient alternative promoters,
novel transcription factor-binding sites, potent enhancers, as well as
small- and long-non-coding RNAs ((Bourque et al., 2018; del Rosario
et al., 2014; Jacques et al., 2013; Kelley and Rinn, 2012); and refer-
ences therein). In human preimplantation embryogenesis and human
embryonic stem cells (hESC), activation of regulatory loci derived from
human endogenous retroviral sequences appears to play a critically
important role (Durruthy-Durruthy et al., 2016; Fort et al., 2014;
Glinsky, 2015a,b, 2016a,b,c, 2017, 2018a, Glinsky et al., 2018; Goke
et al., 2015; Grow et al., 2015; Koyanagi-Aoi et al., 2013; Kunarso et al.,
2010; Lu et al., 2014; Ohnuki et al., 2014; Santoni et al., 2012; Smith
et al., 2014; Wang et al., 2014; Xue et al., 2013; Yan et al., 2013). We
showed that sequences derived from TEs contribute to creation of
thousands of these human-specific genomic regulatory loci (Glinsky,
2015a). Most loci are also bound by the transcription factors (TF)
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NANOG, OCT4 (POU5F1), and CTCF proteins suggesting a regulatory
role during early-stage embryogenesis and relevance to developmental
disorders and cancer (Glinsky, 2015a,b, 2016a,b).
However, in previous analyses, the definition of regulatory regions,
such as enhancers, was based only on sequence conservation, chromatin
features such as histone modifications, chromatin accessibility, and TF
binding (Ernst et al., 2011, 2016; Hoffman et al., 2013; Visel et al.,
2007), and associated biochemical events (e.g., bi-directional tran-
scription (Andersson et al., 2014; Melgar et al., 2011; Wu et al., 2014)),
but lacked direct functional evidence and only select candidates were
successfully validated (Andersson et al., 2014; Wu et al., 2014). In
consequence, the functional significance of primate- and human-spe-
cific regulatory sequences remains unclear.
Recently, massively parallel reporter assays have been developed to
address this bottleneck, providing a direct genome-wide functional
readout of enhancer activity (Arnold et al., 2013; Barakat et al., 2018;
Ernst et al., 2016). In our implementation, the discovery of active en-
hancers was made possible by combining chromatin im-
munoprecipitation with a reporter assay. Application of this technique,
termed ChIP-STARR-seq, to human embryonic stem cells (hESCs)
identified thousands of functional enhancers (Barakat et al., 2018)
(resource available at http://hesc-enhancers.computational-
epigenetics.org/). To maintain the pluripotent state, enhancers in
hESC are bound by pluripotency TFs and associate with enhancer-spe-
cific histone marks. However, only a fraction of loci marked by NANOG,
OCT4, H3K27ac and H3K4me1 function as enhancers in hESC. These
observations highlight the importance of critically examining the as-
sociation of enhancers with DNA segments identified as primate- and
human-specific TFBS.
In this contribution, we show that conserved in primates' sequences
harbor the majority of functional enhancers in both primed and naïve
hESC (83.8% and 84.2%, respectively). Additionally, we identify a
subset of 1619 enhancer sequences that is human-specific and which
are associated with human-specific binding sites of the ESC-linked TFs
NANOG and OCT4. We also note that 5697 enhancers that are active in
different pluripotent states (Invariant module) are particularly enriched
in human-specific sequences and that human-specific and conserved in
primates enhancers in this module are associated with different biolo-
gical roles. Our detailed exploration of the evolutionary framework of
functional enhancers in hESC indicate that the transcriptional control of
pluripotency underwent major changes during the evolution of pri-
mates and that this network continues to evolve after the divergence of
modern humans from other Great Apes.
2. Results and discussion
2.1. Evolutionary origins of active enhancers in hESC
We focused our analysis on DNA sequences of active enhancers
comprising of 32,353 and 36,417 functional regulatory elements in
primed and naïve hESCs, respectively (Barakat et al., 2018) (Fig. 1a,
Table 1). Within these functional enhancers, two modules of enhancers
were distinguished: those overlapping ESC enhancers previously de-
fined by signatures of TFBS and histone modifications (Core module)
and those lacking these signatures (Extended module) (Barakat et al.,
2018). We sought to further examine the potential functional sig-
nificance of these enhancer modules by evaluating them in the context
of evolutionary conservation. To this end, we defined enhancer se-
quences with at least 95% sequence identity during direct and re-
ciprocal conversions between human, chimpanzee, and bonobo gen-
omes, as conserved in primates (Fig. 1b). This definition indicates high
sequence conservation during ~8 million years of evolution. Conserved
in primates sequences constitute the majority of functional enhancer
sequences in both pluripotent states examined (primed= 83.8%,
naïve= 84.2%) with a notable difference (p=2.64 ∗ 10−203; two-
tailed Fisher's exact test) between the Core (93.8%) and Extended
module (80.5%). On the other hand, 6.2% and 19.5% of active en-
hancers' sequences of the Core and the Extended modules, respectively,
could be assigned to the divergent in humans' category (Table 1)
comprising regulatory DNA sequences manifesting> 5% divergence
after human/chimpanzee split.
In contrast, human DNA sequences that are highly conserved in
rodents (as defined by direct and reciprocal conversions between
human and mouse genomes at 95% sequence identity) represent only a
small fraction (~4%) of hESC enhancers, regardless of the module as-
signment (Table 1). Thus, conserved sequences shared with rodents
represent only a small fraction of hESC functional enhancers. Next, we
identified the sequences of functional enhancers that could be defined
as primate-specific because they are not present in the mouse genome
using 10% cut-off of the sequence identity threshold (see Methods).
Using this approach, we found that 28.3% of the Core and 39.7% of the
Extended module enhancers cannot be mapped to the mouse genome
using 10% level of sequence identity threshold (Fig. 1c). These findings
indicate that a significantly higher proportion of Extended module en-
hancers in hESC originates from primate-specific sequences, e.g., se-
quences that are absent in the mouse genome (Extended module com-
pared to Core module; p=1.89 ∗ 10−77; two-tailed Fisher's exact test).
Sizable fractions of functional enhancer sequences assigned to either
Core module (~67%) or Extended module (~56%) manifest sequence
conservation levels of> 10% and<95% in the mouse genome. We
reasoned that the potential functional significance of these intermediate
patterns of sequence conservations is uncertain and evolutionary his-
tories of functional enhancers' sequences manifesting these inter-
mediate sequence conservation levels cannot be ascertained using the
comparisons with rodent genomes. Because traces of their origin still
can be found in the mouse genome, parental sequences may have been
present in the genome of common ancestors and mutated to evolve into
sequences operating as active enhancers in hESC.
In summary, our analyses point to a high sequence conservation of
functional enhancer sequences over ~8 million years of primate evo-
lution. Interestingly, despite overall similarity between primates, a
subset of enhancers lacking strong associated chromatin marks
(Extended module) manifests stronger changes compared to the Core
module, indicating that these regulatory elements may be a relatively
recent evolutionary addition to the functional enhancer network of
hESCs.
2.2. Identification of human-specific sequences operating as active
enhancers in hESC
We defined enhancer sequences not mapping to chimpanzee and
bonobo as human-specific. This analysis identified a total of 1619
human-specific enhancers (Figs. 1b, 2a). Of these, 1034 were active in
primed hESC (3.2% of total active enhancers) compared to 963 (2.7% of
total active enhancers) in naive hESC. A substantial number (n=378;
retention rate= 39.3%) of human-specific enhancers show activity
both in primed and naïve hESC (Table 2), which is a significantly higher
proportion than that of all functional enhancers (retention rate= 18%;
p=5.68 ∗ 10−22; two-tailed Fisher's exact test).
As previously observed for primate-specific enhancers, differential
abundance between Core and Extended module enhancers were also
found for human-specific enhancers, with 0.5% and 4.1% of enhancers
mapped to human-specific sequences, respectively (p=5.029 ∗ 10−80;
two-tailed Fisher's exact test; Fig. 2b). Similarly, sequences of active
enhancers not conserved in non-human primates were more frequent in
the Extendedmodule (“divergent in humans sequences”= all sequences
that are not conserved in primates; Core=6.2%, Extended=19.5%;
p=2.64 ∗ 10−203).
We conclude that the large set of conserved in primates enhancers in
hESCs is complemented by 1619 human-specific enhancers, suggesting
that regulatory networks governed by hESC enhancers underwent a
major extension during primate evolution and further evolved after the
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divergence of humans.
2.3. Characterization of an invariant module of enhancers in primed and
naive hESC
We next focused our analysis on the set of 5697 enhancers that
retain activity in both primed and naïve hESC (Invariant module;
Figs. 1a, 3). Consistent with our original results (Barakat et al., 2018),
functional enrichment analyses with GREAT (McLean et al., 2010)
confirmed that these enhancers were enriched near genes involved in
the negative regulation of cell differentiation and developmental pro-
cesses, as well as positive regulators of stem cell maintenance (Sup-
plemental Table S1). Interestingly, we also found an enrichment of
genes implicated in the post-implantation stages of embryonic devel-
opment and early neurodevelopmental stages.
Conserved in primates sequences constitute 80.5% of the Invariant
module, while another relatively high proportion (6.6%) are human-
specific (a total of 378 regulatory sequences; Tables 3–5). The sig-
nificant enrichment of human-specific enhancers in the Invariant
Fig. 1. Functional enhancers in human embryonic stem cells are dominated by conserved sequences.
(A) Schematic overview of functional enhancers identified in (Barakat et al., 2018) (Barakat et al., 2018).
(B) Schematic overview of conservation classes used in this study.
(C) Bar graph showing the percentage of enhancer sequences overlapping with different conservation classes. P: All: functional enhancers identified in primed hESCs.
P: Core: functional enhancers identified in hESCs overlapping with the core enhancer module. P: Ext: functional enhancers identified in hESCs overlapping with the
extended enhancer module. N: functional enhancers identified in naïve hESCs. TFBS: transcription factor binding sites.
Table 1
Evolutionary histories of the functional hESC enhancers assigned to distinct modules.
Classification category Core module Extended module P value* Primed hESC Naïve hESC P value*
hg19 7948 24,405 32,353 36,417
hg38 (95% sequence identity conversion) 7945 24,318 0.862 32,263 36,333 0.966
hg38 conversion, % 99.96 99.64 99.72 99.77
Primate-specific, n 2246 9652 11,898 12,830
Primate-specific, % 28.27 39.69 6.11E-77 36.88 35.31 0.00002
Conserved in rodents, n 330 916 1246 1504
Conserved in rodents, % 4.15 3.77 0.123 3.86 4.14 0.067
Conserved in primates, n 7455 19,572 27,027 30,601
Conserved in primates, % 93.83 80.48 2.64E-203 83.77 84.22 0.108
Divergent in humans, n 490 4746 5236 5732
Divergent in humans, % 6.17 19.52 2.64E-203 16.23 15.78 0.108
Human-specific, n 36 998 1034 963
Human-specific, % 0.45 4.10 5.029E-80 3.20 2.65 0.0000169
*, p values were estimated using the 2-tailed Fisher's exact test; primate-specific, human-specific, conserved in rodents, and conserved in primates sequences were
identified as described in the methods; primate-specific loci were defined when enhancer sequences do not intersect any chains in the mouse genome (mm10) with
the sequence identity threshold of 10%; human-specific loci were defined when enhancer sequences do not intersect any chains in the genomes of both Chimpanzee
and Bonobo with the sequence identity threshold of 10%; Numbers of enhancers in the divergent in humans category were calculated by subtracting the number of
highly-conserved in primates enhancers from the total number of enhancers in the corresponding classification category.
Fig. 2. Human-specific enhancer evolution in embryonic stem cells.
A) Venn diagram showing the overlap of human-specific active enhancer se-
quences in primed and naïve hESCs.
B) Bar diagram showing the conservation of human-specific sequences across
different enhancer groups, as indicated in Fig. 1C.
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module was confirmed also in independent comparisons to the Core and
Extended modules, and to active enhancers in naïve hESC (Tables 4–5).
Functional enrichment analysis using Enrichr (Chen et al., 2013)
showed that conserved in primates sequences where associated with
many processes linked to hESC biology (such as transcriptional reg-
ulation of human pluripotent stem cells), whereas human-specific se-
quences also showed enrichment for other processes related to human
reproduction and fertilization (Fig. 3B). Notably, conserved in primates
components of the Invariant module are linked to genes down-regulated
upon depletion of pluripotency factors (e.g., OCT4, SOX2, NANOG),
whereas genes linked to the human-specific component are most af-
fected by the depletion of global epigenetic regulators such as TET1/2/
3. Genes linked to human-specific functional enhancers impact EPHA-
mediated growth cone collapse and apoptosis, whereas conserved in
primates component genes affect EPHB-mediated forward signaling and
Sema4D induced cell migration and growth cone collapse (Fig. 3B).
Human-specific functional enhancer sequences are components of
the more broadly-defined evolutionary category designated divergent
in human sequences (Materials & Methods), which explain why they
manifest similar patterns of enrichment (Tables 3–5). Notably, the en-
richment of divergent in human sequences was not observed when the
human-specific sequences were subtracted (Tables 4–5) indicating that
the observed enrichment effects are linked to human-specific sequences
operating in hESC as functional enhancers.
Overall, our analyses indicate that enhancers active in different
pluripotent states (the Invariantmodule) underwent substantial changes
after the divergence of humans and Great Apes.
2.4. Association of human-specific TF binding sites and active enhancers
In earlier work we defined human-specific (hsTFBS) and primate-
specific (psTFBS) binding sites for pluripotency master TFs NANOG and
Table 2
Increased numbers of human-specific naïve hESC functional enhancers share common genomic coordinates* with the extended module & core module functional
enhancers of primed hESC.
Classification category Naïve hESC (observed) Naïve hESC (expected)** Enrichment P value***
Number of human-specific functional enhancers 963 NA
Percent 100.00 NA
ESC core module Primed hESC (n=36) 20 6 3.33 0.0089
Percent 2.08 0.62
Extended module Primed hESC (n=998) 358 180 1.99 1.40E-19
Percent 37.18 18.69
Extended & core modules Primed hESC (n=1034) 378 186 2.03 5.68E-22
Percent 39.25 19.31
*, Common genomic coordinates were defined as the identical chromosomal locations of the individual functional enhancers and the numbers of enhancers having
the same chromosomal locations were computed for each functional enhancers' category; **, Expected number of enhancers in naïve hESC was estimated based on
the overall fraction of 18% maintained in High-High functional enhancers' category in primed and naïve hESC; ***, p values were estimated using the 2-tail Fisher's
exact test.
Fig. 3. Enhancers displaying activity in primed and naïve hESCs are composed of conserved in primates and human-specific sequences.
(A) Pie chart showing the fraction of invariant enhancers that are conserved in primates or human-specific sequences.
(B) Functional enrichment analysis using Enrichr (Chen et al., 2013) of conserved in primates and human-specific invariant enhancers.
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OCT4 by sequence conservation analyses (Glinsky, 2015a). However, it
was previously not possible to assess the functional relevance of the
evolutionary conservation of TF binding. For instance, psTFBS comprise
only ~30%, and hsTFBS only 1%, of all TFBS in hESCs (Glinsky, 2015a;
Kunarso et al., 2010), yet it is unknown what numbers of primate-
specific and human-specific TFBS are associated with functional en-
hancers in hESC.
We consistently observed strong associations of human-specific
functional enhancers with independently-defined hsTFBS (Tables 6, 7):
About half of all human-specific functional enhancer sequences are
located in close proximity (± 10 kb) to hsTFBS occupied by NANOG
(primed=47.5%, naïve=44.3%) or OCT4 (primed= 56.4%,
naïve= 49%) (Table 6). OCT4 and NANOG binding sites were enriched
in our dataset of active enhancers by design of the reporter assay
(which used DNA immunoprecipitated for OCT4 and NANOG as well as
for the histone marks H3K27ac and H3K4me1 as inputs), but hsTFBS
definitions were based on independent sets of laboratory experiments
and computational analyses. It is thus reassuring to see this overlap.
Importantly, the definition of human-specific sites is independent of
both sets of experiments, using instead a lack of intersection with any
chains in the reference genomes of both chimpanzee and bonobo. This
definition indicates that these sequences are absent in genomes of our
evolutionary closest relatives.
Detailed examination of different enhancer modules showed no
strong differences, with 66.7% of human-specific sequences in the Core
module and 61.5% of those in the Extended module mapping close to
any hsTFBS (Table 7). Strikingly, a large proportion of human-specific
enhancers (Core module= 50.0%; Extended module= 41.8%;
naïve=37.9%) are associated with overlapping binding sites for both
NANOG and OCT4 (Fig. 4 and Table 7).
We further confirmed our results by stringent Genome-wide
Proximity Placement Analysis (GPPA) of human-specific functional
enhancers co-localizing with hsTFBS (co-localization is scored when the
enhancer and TFBS occupy the exactly same genomic sequence), as
done previously (Glinsky, 2015a, 2016a,b, 2018a). Briefly, this
methods gauges the significance of overlaps between two types of
genomic elements (here, active enhances and hsTFBS; see Methods and
(Glinsky, 2015a, 2016a,b, 2018b). We consistently observed a sig-
nificant co-localization of hsTFBS (NANOG, p=2.03 ∗ 10−06; CTCF,
p=1.46 ∗ 10−08; OCT4, p=8.91 ∗ 10−33) with functional enhancers
that are active in both primed and naïve hESC (Invariant module;
Table 8). Co-localizations of all hsTFBS (NANOG, p=5.01 ∗ 10−19;
CTCF, p=6.33 ∗ 10−09; OCT4, p=5.04 ∗ 10−20) with sequences of
functional enhancers remain consistently significant when all instances
of overlaps were scored (Table 8). In contrast to hsTFBS, psTFBS appear
to manifest less consistent co-localization patterns with functional
Table 3
Invariant (master) module of hESC functional enhancers comprises 5697 enhancers maintaining common genomic coordinates* during transition from primed to
naïve pluripotency state.
Classification category Number of enhancers Percent Expected*** Enrichment P value**
Conserved in primates active enhancers 4589 80.55 4772 0.96 8.36E-06
Extended module 2665 46.78 3456 0.77 5.35E-50
ESC core module 1924 33.77 1316 1.46 1.37E-36
Divergent in humans active enhancers 1108 19.45 925 1.20 8.36E-06
Extended module 971 17.04 838 1.16 0.0007
ESC core module 137 2.40 87 1.58 0.0009
Human-specific active enhancers 378 6.64 183 2.07 2.21E-17
Extended module 358 6.28 176 2.03 5.58E-16
ESC core module 20 0.35 6 3.15 0.0093
Invariant (Master) stemness module of active enhancers 5697 100.00 5697 1.00 NA
Extended module 3636 63.82 4294 0.85 5.20E-41
Core module 2061 36.18 1403 1.47 5.20E-41
*, Common genomic coordinates were defined as the identical chromosomal locations of the individual functional enhancers and the numbers of enhancers having
the same chromosomal locations were computed for each functional enhancers' category; **, p values were estimated using the 2-tailed Fisher's exact test; ***,
expected numbers of enhancers in each category were estimated based on the distribution of the corresponding enhancers' categories in the primed state hESC;
numbers of enhancers in the divergent in humans category were calculated by subtracting the number of conserved in primates enhancers from the total number of
enhancers in the corresponding classification category.
Table 4
Invariant stemness module of hESC functional enhancers is enriched for human-specific enhancers and evolutionary distinct categories of the core module functional
enhancers.
Classification category Invariant module Percent Primed hESC unique loci Percent Enrichment vs primed P value*
Conserved in primates active enhancers 4589 80.55 22,438 84.46 0.95 1.11E-12
Extended module 2665 46.78 16,907 63.64 0.74 5.14E-121
Core module 1924 33.77 5531 20.82 1.62 6.60E-92
Divergent in humans** active enhancers 1108 19.45 4128 15.54 1.25 1.11E-12
Extended module 971 17.04 3775 14.21 1.20 7.32E-08
Core module 137 2.4 353 1.33 1.81 1.52E-08
Human-specific active enhancers 378 6.64 656 2.47 2.69 5.46E-49
Extended module 358 6.28 640 2.41 2.61 2.40E-44
Core module 20 0.35 16 0.06 5.81 3.31E-07
Divergent in humans without human-specific 730 12.81 3472 13.07 0.98 0.618
Extended module 613 10.76 3135 11.80 0.91 0.027
Core module 117 2.05 337 1.27 1.62 1.31E-05
Total number of enhancers 5697 100 26,566 100.00 1.00
Extended module 3636 63.82 20,682 77.85 0.82 3.14E-103
Core module 2061 36.18 5884 22.15 1.63 3.14E-103
*, p values were estimated using the 2-tailed Fisher's exact test; **, numbers of enhancers in the divergent in humans' category were calculated by subtracting the
number of conserved in primates' enhancers from the total number of enhancers in the corresponding classification category.
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enhancer sequences and in some instances significantly less co-locali-
zation events were observed than expected (Table 9).
Collectively, our analyses highlight a strong overlap of hsTFBS for
master pluripotency regulators with human-specific functional en-
hancers in hESC. However, the majority of these hsTFBS (64–67%) was
not active as enhancers, affirming that identification of hsTFBS alone is
not sufficient for accurate enhancer prediction. Consistent with this
conclusion, even larger fractions of primate-specific TFBS for OCT4 and
NANOG (77–83%, respectively) did not to display enhancer activity
(Table 9)
2.5. Not all conserved in primates sequences are functional enhancers
Our preceding analyses have clearly demonstrated that the majority
of DNA sequences underlying active enhancers in hESCs has been
highly conserved in humans, chimpanzee, and bonobo. We would like
to underscore that high sequence conservation alone or in conjunction
with enhancer-associated chromatin marks does not necessarily entail
or reliably predict the enhancer activity. We had previously generated
hESCs with by CRISPR-Cas9-mediated deletions of both active enhancer
sequences (n=5) and DNA sequences that had also been measured in
our assay but were found to lack enhancer activity (n=6). These ex-
periments yielded altered target gene expression only for deletions of
active enhancers (Barakat et al., 2018). All deleted control and en-
hancer regions were highly conserved in primate (100% of bases, 100%
of span) and also had chromatin-based markers of putative enhancers
(e.g., DNaseI clusters and TFBS for NANOG and OCT4) (Fig. 5 and
Supplemental Figs. 1 and 2, and data not shown).
These experiments together with the additional analysis presented
here established that evolutionary conservation alone or in combina-
tion with chromatin features are useful means for stratification and
rationalization of enhancers, but must be combined with direct func-
tional assays for reliable enhancer identification.
2.6. A majority of DNA segments operating as functional enhancers in hESC
maintained sequence conservation during 30 million years of primate
evolution
Our previous analyses identified DNA sequences that are highly
conserved in humans, chimpanzee, and bonobo and manifest enhancers'
activities in primed and naïve hESC (Table 1). This indicates that a
prominent fraction of hESC functional enhancers originates from DNA
sequences that retained at least 95% of sequence identity during ~8
million years of primates' evolution. It was of interest to extend the
sequence conservation analyses of this highly conserved in primates'
class of functional enhancers by including genomes of other non-human
primates and rodents (Table 10). We included in this analysis the re-
ference genomes of four non-human primates (Gorilla, Orangutan,
Gibbon, and Rhesus) and two rodent species (mouse and rat). To en-
hance the stringency of the analytical pipeline, we also analyzed two
additional independent reference genome databases of Chimpanzee
(PanTro6) and Bonobo (PanPan1) that were not utilized in the previous
analyses defining the evolutionary sequence conservation categories of
functional enhancers (Table 10). Of importance is that the PanTro6
genome was generated without so called “humanized” genomic regions
(Kronenberg et al., 2018), which gives a better estimation of con-
servation levels. The results of these analyses demonstrate that> 91%
of functional enhancers' sequences that are highly conserved in gen-
omes of humans, chimpanzee, and bonobo, are also highly conserved in
the genomes of Gorilla and Orangutan. Furthermore,> 75% of DNA
sequences representing this category of functional enhancers are highly
conserved in the Rhesus genome as well. In striking contrast, only ~4%
of these sequences are conserved in rodents' genomes (Table 10). Col-
lectively, these observations highlight a significant contribution of the
Great Apes' evolution to the genomic landscape of DNA sequences op-
erating as functional enhancers in hESC and indicate that a majority ofTa
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functional enhancers maintained at least 95% of sequence conservation
during ~30 million years of primates' evolution.
2.7. Distinct patterns of evolutionary histories of hESC functional enhancers
and candidate hESC enhancers defined based on chromatin marks
To gain further insights into evolutionary origins of DNA segments
operating in hESC as enhancers, we compared the profiles of evolu-
tionary categories of hESC functional enhancers and 7006 sequences
defined as putative hESC enhancers based on chromatin marks, in-
cluding 684 super-enhancers (Supplemental Tables S2 and S3) (Hnisz
et al., 2013). Because chromatin marks-defined putative enhancers
were identified in primed hESC (Hnisz et al., 2013), the comparisons
were made with primed hESC functional enhancers. These analyses
demonstrate that chromatin marks-defined putative enhancers' se-
quences and DNA sequences functioning in hESC as active enhancers
manifest significant differences of the quantitative balance of distinct
evolutionary categories (Supplemental Table S2). The most apparent
and consistent differences were the significantly increased fractions of
primate-specific (p=8.16E-75) and human-specific (p=8.89E-67)
sequences operating in primed hESC as functional enhancers compared
to 7006 chromatin marks-defined putative enhancers (Supplemental
Table S2, last column). This pattern of differences was also observed
when comparisons were made of functional enhancers' sequences with
DNA sequences of either the 6322 conventional enhancers or 684 super-
enhancers separately (Supplemental Table S2). Notably, DNA segments
defined as super-enhancers manifest a significantly lower fraction of
highly-conserved in primates' sequences compared to either conven-
tional chromatin marks-defined putative enhancers (p=5.42E-33;
Supplemental Table S2) or hESC functional enhancers (p=3.39E-27; 2-
tailed Fisher's exact test). Analysis of genomic coordinates of super-
enhancers and functional enhancers revealed that 476 of 684 (69.6%)
of DNA regions defined as super-enhancers contain at least one DNA
segment operating as active enhancers identified in primed hESC
(Supplemental Table S3). Taking into account functional enhancer se-
quences operating in both primed and naïve hESC, a total of 579 of 684
(84.7%) of super-enhancers harbor active enhancer sequences (Sup-
plemental Table S3). A smaller fraction of conventional chromatin
marks-defined enhancers (1680 candidate enhancers; 26.6%) overlap
with functional enhancer sequences identified in primed hESC. Next,
we confirmed differences in evolutionary histories of enhancers' se-
quences defined by different methodological approaches by performing
the sequence conservation analyses only on overlapping enhancers'
sequences, thus restricting the analyses to 2156 chromatin marks-de-
fined enhancers that harbor 3463 functional enhancers identified in
primed hESC (Supplemental Table S4). Collectively, the results of these
analyses indicate that DNA segments defined as functional enhancers in
hESC represent evolutionary-conserved sequences operating as active
Table 6
Genomic association* of human-specific hESC functional enhancers with human-specific NANOG and OCT4 (POU5F1) binding sites.
Human-specific NANOG binding sites (HSNBS)
Classification category Number of human-specific functional enhancers Near HSNBS, n Near HSNBS, % Number of HSNBS**
Extended & core modules human-specific hESC enhancers 1034 491 47.5 227
Human-specific Naïve hESC active enhancers 963 427 44.3 200
Human-specific OCT4 binding sites (HSOBS)
Classification category Number of human-specific functional enhancers Near HSOBS, n Near HSOBS, % Number of HSOBS**
Extended & core modules human-specific hESC enhancers 1034 583 56.4 1425
Human-specific Naïve hESC active enhancers 963 472 49.0 1258
HSNBS, human-specific NANOG binding sites; HSOBS, human-specific OCT4 binding sites; *, genomic associations were defined based on co-localizations of the
HSNBS and/or HSOBS and human-specific hESC functional enhancers which were identified within the 10 Kb windows upstream and downstream of each enhancers'
genomic coordinates in the hg38 release of the human reference genome; **, HSNBS and HSOBS associated with functional enhancers were defined based on the
location of their genomic coordinates within±10 Kb windows of the corresponding enhancer genomic coordinates.
Table 7
Genomic association* of human-specific hESC functional enhancers with
human-specific TFBS occupied by both NANOG and OCT4.
Associated human-specific TFBS Number of functional
enhancers
Percent
36 human-specific ESC module functional
enhancers
24 66.67
Human-specific NANOG-binding sites 22 61.11
Human-specific OCT4-binding sites 20 55.56
Human-specific NANOG & OCT4 binding sites 18 50.00
Human-specific NANOG-binding sites only 4 11.11
Human-specific OCT4-binding sites only 2 5.56
998 human-specific extended module
functional enhancers
614 61.52
Human-specific NANOG-binding sites 469 46.99
Human-specific OCT4-binding sites 563 56.41
Human-specific NANOG & OCT4 binding sites 417 41.78
Human-specific NANOG-binding sites only 52 5.21
Human-specific OCT4-binding sites only 145 14.53
963 human-specific Naïve hESC functional
enhancers
534 55.45
Human-specific NANOG-binding sites 427 44.34
Human-specific OCT4-binding sites 472 49.01
Human-specific NANOG & OCT4 binding sites 365 37.90
Human-specific NANOG-binding sites only 62 6.44
Human-specific OCT4-binding sites only 107 11.11
HSNBS, human-specific NANOG binding sites; HSOBS, human-specific OCT4
binding sites; *, genomic associations were defined based on co-localizations of
the HSNBS and/or HSOBS and human-specific hESC functional enhancers
which were identified within the 10 Kb windows upstream and downstream of
each enhancers' genomic coordinates in the hg38 release of the human re-
ference genome; HSNBS and HSOBS associated with functional enhancers were
defined based on the location of their genomic coordinates within±10 Kb
windows of the corresponding enhancer genomic coordinates.
Fig. 4. Human-specific enhancers and transcription factor binding sites.
Bar graph showing the percentage of enhancers from different categories (as in
Fig. 1C) that overlap with human-specific NANOG and OCT4 binding sites, or
with binding sites co-occupied by both NANOG and OCT4. See text and Tables 6
and 7 for details.
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enhancers within a majority of continuous linear genomic regions de-
fined as super-enhancers, while only a small fraction of conventional
chromatin marks-defined enhancers overlap functional enhancer se-
quences. Overall, active enhancers and putative functional genomic
elements defined based on different chromatin features manifest similar
conservation profiles with the highly conserved in primates sequences
being the prevalent evolutionary category, while conserved in rodent
sequences representing only a small minority (data not shown). These
observations underscore the notion that the sequence conservation
along or in combination with different chromatin marks is not sufficient
to identify or reliably predict genomic sequences operating as active
enhancers in hESC, in line with our previous findings (Barakat et al.,
2018).
2.8. Implications of analyses of sequence conservation patterns of hESC
functional enhancers
We carried out an analyses of evolutionary conservation patterns of
different modules of active enhancers to infer their evolutionary history
and compared them to other types of functional genomic elements
(Tables 1–10; Supplemental Tables 2–4; and data not shown). Results of
these analyses support the conclusion that genomic sequences operating
in hESC as functional enhancers represent a collection of sequences
with apparently different evolutionary histories, including a prominent
majority of highly-conserved in primates sequences supplemented with
a sizable number of human-specific DNA segments. Notably, DNA se-
quences conserved in rodents represent only a small fraction of genomic
segments defined as active enhancers in hESC, strongly arguing that
regulatory networks governing the stemness phenotype in hESC are
vastly different from mouse ESC and predominantly comprise of reg-
ulatory elements created during primates' evolution. Interestingly,
genes associated with conserved in primates and human-specific se-
quences of functional enhancers appear to contribute to biologically
distinct functions (Fig. 3; Supplemental Table S1; and data not shown),
suggesting that they may operate synergistically during human devel-
opment. Overall, the conservation profiles of active enhancers defined
by comparisons of their sequences in reference genomes of humans,
non-human primates, and rodents appear similar to other functional
genomic regions considered highly-conserved in evolution such as
exons and DHS regions (data not shown). More broad comparisons of
conservation patterns of defined functional genomic elements such as
active enhancers to the genome-wide interspecies conservation are
confounded by several factors. Estimates of genome-wide mutation
rates established that they vary among different regions of the human
genome (Harpak et al., 2016). Genome-wide mutation rates are also
affected by multiple factors: for example, they are different between
males and females (Li et al., 2002) and known to correlate with father's
age (Kong et al., 2012). Genome-wide comparisons of the interspecies
Table 8
Co-localization of human-specific transcription factor binding sites with active enhancers (RPP > 138) in naïve and primed hESC.
Classification category Number of scored loci Percent Expected Observed/expected ratio** P value*
Human-specific NANOG-binding sites (n=826) 803 97.22
Naïve hESC Active Enhancers 97 35.53
Naïve & Primed hESC Active Enhancers 99 36.26 49 2.02 2.03E-06
Primed hESC Active Enhancers 77 28.21
NANOG all Active Enhancers 273 100.00 120 2.28 5.01E-19
Human-specific OCT4-binding sites (n=2386) 2277 95.43
Naïve hESC Active Enhancers 198 23.13
Naïve & Primed hESC Active Enhancers 381 44.51 154 2.47 8.91E-33
Primed hESC Active Enhancers 277 32.36
OCT4 all Active Enhancers 856 100.00 569 1.50 5.04E-20
Human-specific CTCF-binding sites (n=591) 564 95.43
Naïve hESC Active Enhancers 41 20.40
Naïve & Primed hESC Active Enhancers 89 44.28 36 2.47 1.46E-08
Primed hESC Active Enhancers 71 35.32
CTCF all Active Enhancers 201 100.00 113 1.78 6.33E-09
*, p values were estimated using the 2-tailed Fisher's exact test; **, expected numbers of co-localized loci of transcription factor binding sites and active enhancers
were estimated at 15% for NANOG; 25% for OCT4; and 20% for CTCF; expected numbers of Naïve & Primed active enhancers were estimated at 18% (Barakat et al.,
2018).
Table 9
Co-localization of primate-specific transcription factor binding sites with active enhancers (RPP > 138) in naïve and primed hESC.
Classification category Number of scored loci Percent Expected Observed/expected ratio** P value*
Primate-specific NANOG-binding sites (n=28,843) 28,843 100.00
Naïve hESC Active Enhancers 2228 45.25
Naïve & Primed hESC Active Enhancers 885 17.97 886 1.00 1
Primed hESC Active Enhancers 1811 36.78
NANOG all Active Enhancers 4924 100.00 4326 1.14 1.23E-11
Primate-specific OCT4-binding sites (n=13,877) 13,877 100.00
Naïve hESC Active Enhancers 1159 35.56
Naïve & Primed hESC Active Enhancers 894 27.43 587 1.52 1.18E-19
Primed hESC Active Enhancers 1206 37.01
OCT4 all Active Enhancers 3259 100.00 3469 0.94 3.42E-03
Primate-specific CTCF-binding sites (n= 28,626) 28,626 100.00
Naïve hESC Active Enhancers 1031 45.64
Naïve & Primed hESC Active Enhancers 187 8.28 407 0.46 2.02E-22
Primed hESC Active Enhancers 1041 46.08
CTCF all Active Enhancers 2259 100.00 5725 0.39 0
*, p values were estimated using the 2-tailed Fisher's exact test; **, expected numbers of co-localized loci of transcription factor binding sites and active enhancers
were estimated at 15% for NANOG; 25% for OCT4; and 20% for CTCF; expected numbers of Naïve & Primed active enhancers were estimated at 18% (Barakat et al.,
2018).
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conservations is also confounded by the known differences in the
quality of the reference genome sequences for different species (with
the human reference genome sequence quality being vastly superior:
(Kronenberg et al., 2018)). Further complications arise from the ap-
proach called “humanization” of primates' reference genomes, which
involves filing the sequence gaps with the human genome sequences of
the orthologues regions. This problem was only recently resolved for
some Great Apes reference genomes such as the PanTro6 database of
the Chimpanzee genome (Kronenberg et al., 2018). Kronenberg et al.
(2018) report that 83% of the ape genomes can be compared using a
multiple sequence alignment and estimate that 36% of human auto-
somal DNA is subject to incomplete lineage sorting. To address these
potential limitations, we extended our sequence conservation analyses
to include the PanTro6 reference genome database released in 2018
(Table 10). Taking into account all these factors, in addition to the
comparative analyses of different modules of active enhancers in both
primed and naïve hESC, we performed the comparisons of the sequence
conservation patterns of functional enhancers and chromatin marks-
defined candidate enhancers (Supplemental Tables S2–S4). We ob-
served consistent statistically significant differences between functional
enhancers and chromatin marks-defined candidate enhancers reflecting
a relatively higher fraction of evolutionary conserved sequences among
genomic segments operating as active enhancers in hESC. Collectively,
results of these analyses support the conclusion that the level of se-
quence conservation is not uniquely distinct feature of functional en-
hancers and combinations of sequence conservation analyses with any
other chromatin-associated enhancers' features are not sufficient to
distinguish and reliably identify functional enhancers.
3. Conclusions
Genomic screens for candidate enhancers typically utilize enhancer-
associated molecular features such as histone marks, bidirectional
transcription, and chromatin accessibility to define putative enhancers.
These experimental approaches were recently extended by direct,
genome-wide readouts of the functional activity of putative enhancers
(Arnold et al., 2013; Barakat et al., 2018; Ernst et al., 2016). Here we
have used the resource of enhancers in hESCs that we have recently
made available (Barakat et al., 2018) to assess enhancer activity in the
light of evolution.
Sequences that are highly conserved during ~8 million years of
primate evolution were found to dominate the genomic landscape of
functional enhancers in both primed and naïve hESC. Conserved in
primates enhancers are complemented by a set of human-specific en-
hancers that are preferentially associated with human-specific TFBS of
NANOG and OCT4. Conserved in primates enhancers are critical to
regulate pluripotency related genes while human-specific enhancers
appear to be also linked to other processes, such as human reproduc-
tion. These observations suggest that an essential genomic regulatory
network for human embryonic stem cells was established during pri-
mate evolution to maintain a distinct from rodent primate stemness
phenotype. Additionally, recent divergent evolution has resulted in an
extended network to drive human-specific developmental traits in
modern humans.
Interestingly, genes that are predictive of cancer survival across 17
human malignancies (Uhlen et al., 2017) are significantly enriched near
DNA sequences operating as active hESC enhancers (data not shown),
consistent with a role of stem cell regulatory networks in development
of clinically lethal cancer phenotypes (Glinsky, 2015b, 2016a,c; Glinsky
et al., 2005). This observation stresses the relevance of the examination
of hESC functional enhancers not only for developmental and stem cell
biology, but also to human disease. Collectively, our analyses illustrate
that active enhancers operating in primed and naïve hESC represent
complimentary sets of a tractable model for the interrogation of precise
structure-activity-phenotype relations and a resource for dissecting the
genetic elements governing evolutionarily stable and species-specific
features of development, physiology and pathology.
4. Materials and methods
4.1. Definitions of active enhancers in hESCs
Data about enhancer activity in H9 human embryonic stem cells was
obtained from Barakat et al. (Barakat et al., 2018). Briefly, this dataset
Fig. 5. Not all conserved sequences are functional enhancers in hESCs.
Exemplary Genome-browser shot of part of the TCF7L1 and GNAI2 loci. We previously generated cell lines with deletions of the indicated regions by CRISPR-Cas9
genome engineering. Both regions have a similar level of conservation and are marked by various enhancer features. In ChIP-STARR-seq analysis, only the TCF7L1
intronic sequences showed functional enhancer activity. Deletion of this conserved sequences in hESCs did affect gene expression of target genes, whereas the
deletion of a similar conserved intronic region of GNAI2 that did not show activity in ChIP-STARR-seq did not affect target gene expression (Barakat et al., 2018).
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assessed the enhancer activity of 362,358 regions based on a massively
parallel reporter assay using DNA immunoprecipitated for OCT4,
NANOG, H3K27ac, or H3K4me1 as input. 32,353 and 36,417 regions
were identified as active enhancers in primed and naïve hESCs, re-
spectively. Active enhancers in primed hESCs were further dis-
tinguished into two modules, Core and Extended. Core module en-
hancers overlapped with at least one of 76,666 putative enhancers
previously predicted based on TF binding or histone modification
codes, while enhancers assigned to the Extended module lacked this
overlap (Barakat et al., 2018).
4.2. Categories of DNA sequence conservation
Identification of conserved in primates, primate-specific, and
human-specific sequences was performed as previously described
(Glinsky, 2015a, 2016a,b, 2018a). In brief, all categories were defined
by direct and reciprocal mapping using liftOver (Hinrichs et al., 2006).
Specifically:
- Conserved in primates: DNA sequences that have at least 95% of bases
remapped during conversion from/to human (Homo sapiens, hg38),
chimp (Pan troglodytes, v5), and bonobo (Pan paniscus, v2).
- Primate-specific: Functional enhancers' sequences, including con-
served in primates sequences, which failed to map to the mouse
genome (mm10).
- Human-specific: DNA sequences that failed to map at least 10% of
bases from human to both chimp and bonobo genomes.
The human divergent category reflects the more broad classifica-
tion, which is the number of features defined by the subtraction of
highly-conserved in primates' enhancers (having sequence identity of at
least 95% in genomes of humans, chimpanzee, and bonobo) from the
total number of enhancers in the corresponding functional enhancers'
category. This category has been independently determined for the core
module; extended module; primed enhancers; naïve enhancers; and
chromatin marks-defined candidate enhancers. Human-specific en-
hancers represent more restricted evolutionary category, which is de-
fined by the sequences that are absent in genomes of both Chimpanzee
and Bonobo using the sequence identity threshold of 10%. Thus,
human-specific enhancers are included in the more broad divergent in
human category. To infer the putative evolutionary origins, each evo-
lutionary classification was defined independently by running the cor-
responding analyses on all functional enhancers representing the spe-
cific category (the core module; extended module; primed enhancers;
naïve enhancers; chromatin marks-defined enhancers). For example,
human-rodent conversion identify sequences that are absent in the
mouse genome based on the sequence identity threshold of 10%). Some
highly-conserved in primates may be also conserved in rodents (in
reality, only very few are shared with rodent). Non-rodent enhancers
are best defined by the primate-specific classification (absent in the
mouse genome based on the sequence identity threshold of 10%),
which may include highly conserved in primates and human-specific
sequences. However, highly conserved in primates and human-specific
sequences represent non-overlapping evolutionary classifications.
Similarly, highly conserved in primates and human divergent categories
are non-overlapping by definition. Additional comparisons were per-
formed using the same methodology and exactly as stated in the
manuscript text.
4.3. Genome-wide proximity placement analysis
Genome-wide Proximity Placement Analysis (GPPA) of human-
specific enhancers co-localizing with hsTFBS was carried out as de-
scribed previously (Glinsky, 2015a, 2016a,b, 2018b). Briefly, we ex-
amined the significance of overlaps between active enhances and
hsTFBS by first identifying all hsTFBS that overlap with any of the
genomic regions tested in our ChIP-STARR-seq dataset. We then cal-
culated the relative frequency of active enhancers overlapping with
hsTFBS (Table 8). To assess the significance of the observed overlap of
genomic coordinates, we compared the values recorded for hsTFBS with
the expected frequency of active and non-active enhancers that overlap
with all TFBS for NANOG (15%) and OCT4 (25%) as previously de-
termined (Barakat et al., 2018). Our analyses demonstrate that> 95%
of hsTFBS co-localized with sequences in the tested regions of the hESC
genome (Table 8). GPPA allows the evaluation of both direct overlap
and co-localization of defined genomic elements within DNA segments
of specified continuous lengths.
4.4. Functional enrichment analysis
We used the GREAT web interface (version 3.0.0) (http://great.
stanford.edu/public/html/) (McLean et al., 2010) for gene ontology
analysis, using the following settings: basal plus extension, proximal
5 kb upstream and 1 kb downstream, plus distal up to 100 kb, including
curated regulatory domains, and whole genome (hg19) as background.
In addition, we used the Enrichr API (January 2018 version) (Chen
et al., 2013) to test genes linked to enhancers of interest for significant
enrichment in numerous functional categories. To comply with the web
interface, we considered the 1000 genes closest to the tested peaks for
enrichments. In all plots, we report the “combined score” calculated by
Table 10
Distinct conservation patterns among Great Apes and rodents of hESC func-
tional enhancers operating on DNA sequences conserved in genomes of humans,
chimpanzee, and bonobo.
Genome database Species Number of conserved
enhancers
Percent
10.1. Conservation among Great Apes of 7455 core module sequences of primed hESC
functional enhancers that are highly conserved in humans (hg38), chimpanzee
(PanTro5), and bonobo (PanPan2).
PanTro6 Chimpanzee 7424 99.58
PanPan1 Bonobo 7422 99.56
GorGor5 Gorilla 7300 97.92
PonAbe3 Orangutan 6966 93.44
NomLeu3 Gibbon 6207 83.26
RheMac8 Rhesus 5892 79.03
rn6 Rat 287 3.85
mm10 Mouse 328 4.40
10.2. Conservation among Great Apes of 19,572 extended module sequences of primed
hESC functional enhancers that are highly conserved in humans (hg38),
chimpanzee (PanTro5), and bonobo (PanPan2)
PanTro6 Chimpanzee 19,489 99.58
PanPan1 Bonobo 19,480 99.53
GorGor5 Gorilla 18,929 96.71
PonAbe3 Orangutan 17,723 90.55
NomLeu3 Gibbon 14,944 76.35
RheMac8 Rhesus 14,711 75.16
Rn6 Rat 800 4.09
mm10 Mouse 809 4.13
10.3. Conservation among Great Apes of 30,601 sequences of naive hESC functional
enhancers that are highly conserved in humans (hg38), chimpanzee (PanTro5), and
bonobo (PanPan2)
PanTro6 Chimpanzee 30,465 99.56
PanPan1 Bonobo 30,490 99.64
GorGor5 Gorilla 29,727 97.14
PonAbe3 Orangutan 27,987 91.46
NomLeu3 Gibbon 23,881 78.04
RheMac8 Rhesus 23,497 76.79
rn6 Rat 1356 4.43
mm10 Mouse 1375 4.49
Conservation patterns among non-human primates and rodents were evaluated
for hESC functional enhancers operating on DNA sequences that are conserved
in genomes of humans, chimpanzee, and bonobo (Table 1). Numbers of en-
hancers' sequences manifesting at least 95% sequence identity conservation
during direct & reciprocal conversions from/to hg38 human reference genome
database are reported for each species.
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Enrichr, which is a product of the significance estimate and the mag-
nitude of enrichment (combined score c= log(p) ∗ z, where p is the
Fisher's exact test p-value and z is the z-score deviation from the ex-
pected rank).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2019.101456.
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